Reckitt Benckiser wins
According to analytical company DSM Group, which makes the monitoring of the retail commercial market drugs, in 2015 in Russia the sales of condoms compared to the previous year increased by 6% in real terms, to 16.6 million packages. Pharmacy sales grew despite significant price increase: average cost per unit barrier contraception in 2015 has increased by 37% to RUB 211 per pack. As a result, in ruble terms the market grew by 45% to RUB 3.5 billion.
Sales of condoms indeed increase in recent years, confirmed Executive Director of the Russian Association of pharmacy chains Nelli Ignatieva.
General Director DSM Group Sergey shuljak explains the increase in sales of condoms of their relatively low price in comparison of birth control pills: “Despite rising prices due to the fall of the ruble, condoms remain one of the most affordable among categories of contraceptive methods, which is especially important in the fall in people’s incomes. In the last crisis 2008, the demand for these goods also grew up”.
According to DSM, the largest seller of condoms in Russia was the British company Reckitt Benckiser group PLC: mark Contex occupied 43.8% of this market. The leader should brand Durex (owned by the same Reckitt Benckiser) with a share of 30.7%, VIZIT (German CPR Produktions und Vertriebs GmdH) with 13.1 percent. The press service of the companies not responded to the requests .
National Director of Armavir factory of rubber products (produces condoms under the brand “Eros”) Natalya Simonova said that last year the sale of production in real terms grew by 30%, in cash — by 46%, without specifying absolute values. “According to our estimates, the growth stems from the fact that due to the crisis people began to abandon the more expensive contraceptives — hormonal preparations”, — says Simonov.
Did the stocks
In August of last year, the Ministry of industry and trade of the Russian Federation proposed to limit government purchases of some imported medicines, including condoms, used by health agencies. This information also influenced the growth of sales of condoms in 2015. “People rushed to stock up on condoms, not understanding that the proposed restriction was only of public procurement”, — says the Director of the state budgetary institution research Institute for health organization and medical management of the Department of health of Moscow David Melik-Guseinov.
Trade publication Vademecum 10 February, citing the Director of the Department of development of pharmaceutical and medical industry of Ministry of industry and trade Olga Kolotilova reported that condoms were excluded from the current list of imported medicines, which now is coordinated. “The list is now being coordinated by the Federal Executive authorities. <…> It in the same form in which we hung out on regulation.gov.ru. Condoms are only thrown by order of the citizens,” said Kolotilova. In the Ministry of industry and trade Wednesday, 20 February, failed to respond promptly to the request.
The demand for condoms is growing simultaneously with the falling sales of another popular means of contraception — birth control pills. In 2015, pharmacy sales of oral contraceptives, according to DSM Group, fell by 4% in real terms, to 17.4 million packages. “Oral contraceptives — this is a product that constantly needs unlike condoms, so costs are typically higher. During the crisis, the price factor becomes crucial, therefore, people are starting to go off my meds,” explains Shulyak.
According to DSM, the average price for oral contraceptives in 2015 amounted to 779 rubles per unit, for the year it increased by 21%.
While 97% of the Russian market oral contraceptives take imported drugs. The majority of all sales — 51 percent — are in the German company Bayer (drugs “GES”, “yasmin” and “Janine”), another 39% by Hungarian Gedeon Richter (“Regulon”, “Lindinet”). The press service of the companies not responded to the requests .